Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.6.0.2
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenue:    
Products, services, other $ 1,794,749 $ 1,409,991
Grant revenue 181,738 387,700
Total revenue 1,976,487 1,797,691
Costs and expenses:    
Cost of products and services 834,012 609,054
Research and development 1,183,011 1,105,295
Selling and marketing 872,365 745,574
General and administrative 2,822,752 2,902,950
Total operating costs and expenses 5,712,140 5,362,873
Operating loss (3,735,653) (3,565,182)
Other (expense) income:    
Interest expense (4,501,186) (4,146,416)
Other expense (1,112) (36,879)
Impairment loss on investment (373,682)
Gain on extinguishment of embedded derivative liabilities 2,555,180
Change in fair value of derivative liabilities 5,904,649 (2,222,001)
Total other (expense) income 1,028,669 (3,850,116)
Net loss (2,706,984) (7,415,298)
Accrued dividends on convertible preferred stock (23,194)
Net loss applicable to common shareholders $ (2,706,984) $ (7,438,492)
Net loss per share attributable to common stockholders - basic and diluted $ (0.10) $ (0.36)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 27,339,362 20,726,205